Search

everythinglearnresearchcommunity

for

Search:↓

STK11 gene polymorphism does not predict metformin response in PCOS.

Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.

Women with high androgen levels may have more severe COVID-19 symptoms.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Estrogen therapy can reduce skin aging but has cancer risks.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Eating a Mediterranean diet and taking certain supplements may improve symptoms of PCOS.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

New treatments for PCOS show promise, including both medication and non-medication options.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

The review found that current care models for PCOS are not fully effective and more research is needed, especially in low-income countries.

Creating specific biological indicators is important for early detection and treatment of PCOS.

Excess androgens may cause PCOS, not just be a symptom.

Metformin helps manage PCOS by improving metabolism and ovulation, but should be part of a personalized treatment plan.